LiraglutideEvidence & Dosage
First-generation GLP-1 for diabetes/obesity — daily, smaller effect size.
Evidence at a glance
- Total studies
- 816
- With abstract
- 48
- Meta / Systematic / RCT
- 4
- Highly cited
- 7
- Publication years
- 1999–2026
Liraglutide in the context of Peptides
This topic is part of our "Peptides" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.
Go to PeptidesTop studies on Liraglutide
Ranked by influential-citation count and publication year.
Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Nature Medicine2025n=204120 influential citationsLiraglutide, a glucagon-like peptide 1 (GLP-1) agonist and antidiabetic drug, has shown neuroprotective effects in animal models. In this study, we aimed to evaluate the safety and efficacy of liraglutide in mild to moderate Alzheimer's…
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Behavioural brain research201737 influential citationsDiabetes has been identified as a risk factor for cognitive dysfunctions. Glucagone like peptide 1 (GLP-1) receptor agonists have neuroprotective effects in preclinical animal models. We evaluated the effects of GLP-1 receptor agonist,…
Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study
Gut Microbes202524 influential citationsMetformin (Met) and liraglutide (Lira) are preferred diabetes therapies that may improve glycemia by modulating the gut microbiome, but the mechanisms and pathways are unknown and few data exist in youth-onset type 2 diabetes (Y-T2D). In a…
Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation
International Immunopharmacology202423 influential citations<h4>Background and purpose</h4>Renal transplantation and other conditions with transiently reduced blood flow is major cause of renal ischemia/reperfusion injury (RIRI), a therapeutic challenge clinically. This study investigated the role…
Liraglutide suppresses ferroptosis by upregulation NRF2 in type 2 diabetic cardiomyopathy
Peptides202520 influential citationsRecent research indicates that inhibiting myocardial ferroptosis may help alleviate diabetic cardiomyopathy (DCM). Liraglutide (LIRA), a glucagon-like peptide-1 receptor agonist, has been shown to offer cardiovascular protective effects.…
Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety
bioRxiv202312 influential citationsLiraglutide and other agonists of the glucagon-like peptide 1 receptor (GLP-1RAs) are effective weight loss drugs, but how they suppress appetite remains unclear. One potential mechanism is by activating neurons which inhibit…
Liraglutide attenuates clozapine-induced mitochondrial dysfunction and improves energy metabolism in the brain of rats
Biochemical Pharmacology2025n=73 influential citationsChronic use of antipsychotics for schizophrenia (SCZ) often causes metabolic disturbances that exacerbate cognitive impairment, and the underlying mechanisms remain unclear. As a classic antipsychotic, the metabolic toxicity of clozapine…
Unveiling the potential therapeutic role of nifuroxazide and liraglutide combination in mitigating LPS-induced acute lung injury through modulation of AT1R/JAK-2/STAT-3 by ACE2/ Ang1‐7/MasR signaling in male albino rats: in vivo and in silico study
International Immunopharmacology20253 influential citationsThe current study investigated the possible therapeutic role of a combination of liraglutide and nifuroxazide in ameliorating the JAK2/STAT3/NFĸB signaling pathway by augmenting the counter-regulatory ACE2/Ang1-7/MAS receptor axis of the…
A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells
International Journal of Molecular Sciences20253 influential citationsMale fertility has declined over the years, partly due to metabolic disorders such as obesity and Type 2 diabetes. Antidiabetic drugs, including GLP-1 receptor agonists like liraglutide, are widely used to manage these conditions and aid…
The novel GLP-1 / GIP dual agonist DA3-CH is more effective than liraglutide in the MPTP mouse model of Parkinson's disease
European Journal of Pharmacology20253 influential citationsParkinson's disease is the second most common neurodegenerative disease worldwide with a high incidence rate. The abnormality of the Wnt/β-catenin signaling pathway is closely related to the occurrence of Parkinson's disease (PD).…
More topics in Peptides
Peptides Overview
Peptides, BPC-157, TB-500, safety and the state of the evidence.
Administration Routes
Subcutaneous, intramuscular, nasal, oral, topical — bioavailability and safety.
Autoimmunity Risk
Immune modulation can both promote tolerance and tip into dysregulation.
BPC-157
Peptide for tissue regeneration, healing, and athletic recovery.
Cerebrolysin
A pig-brain peptide mix, stroke studies, not approved in Germany.
CJC-1295
GHRH analog, half‑life variants and pulse patterns.
Dihexa
Angiotensin derivative, cognitive/neuroplasticity signals in animal models.
GHK-Cu
Copper peptide for skin health, anti-aging, and wound healing.
GHRP-2
GH releaser, older generation, appetite stimulation as a side effect.
GHRP-6
GH releaser with a strong appetite component.
GLP-1 Rebound
Weight regain after stopping without lifestyle anchors.
GLP-1 Side Effects
Nausea, gastric emptying, muscle loss, pancreatitis risk.
Hexarelin
GH releaser, fast tolerance build-up, cardiac signals.
IGF-1 LR3
Modified IGF-1 with a long half-life — hypertrophy, the cancer-risk debate.
Immune Modulation
Automatisch via Trend Scout entdeckt. Supplements targeting inflammation and immune resilience remain a central research area.. PubMed: 11956 Ergebnisse.
Injection Safety
Sterile technique, bacteriostatic water, skin disinfection — a medical topic.
Ipamorelin
Selective GH releaser, cortisol‑sparing, and stack combinations.
KPV
An alpha-MSH fragment — anti-inflammatory, gut, skin, early research.
LL-37
Antimicrobial peptide, wound healing, immune modulation, early research.
MK-677
Ghrelin mimetic, not strictly a peptide — sleep, appetite, glucose risk.
Related topics from other worlds
Prolactin
Stress/sleep hormone, suppresses testosterone when chronically elevated.
Thyroid & Energy
How thyroid status shapes fatigue, weight and mental clarity.
Alpha-GPC
Choline source for acetylcholine and cognitive performance
Creatine
More than just sport: memory, sleep deprivation, vegan deficits.
Glucose vs Ketones
The brain's fuel sources, ketogenic adaptation, cognitive effects.
Modafinil
Wakefulness, off-label use, tolerance, and addiction potential.